Seagen Inc.
Anti-TIGIT Antibodies
Last updated:
Abstract:
Isolated antibodies or antigen-binding portions that bind to human TIGIT (T-cell immunoreceptor with Ig and ITIM domains) are provided. In some embodiments, the antibody or antigen-binding portion thereof has a binding affinity (K.sub.D) for human TIGIT of less than 5 nM. In some embodiments, the anti-TIGIT antibody blocks binding of CD155 and/or CD112 to TIGIT.
Status:
Application
Type:
Utility
Filling date:
28 Oct 2020
Issue date:
2 Sep 2021